President Trump’s nominee to lead the Drug Enforcement Administration appeared this week before the Senate Judiciary ...

Drug experts say U.S. Attorney General Pam Bondi’s statement ignores critical facts about fentanyl and drug seizures. Not everyone is at risk of dying from a fentanyl overdose, ...

Texas Attorney General Ken Paxton is taking on major companies for what he suspects are using dangerous levels of chemicals.

STAT editors and reporters review the widespread impact of grant cuts, layoffs and policy changes — and also discuss recent ...

That was Photoshop? Terry, you can't do that -- he had -- he-- hey, they're givin' you the big break of a lifetime. You know, you're doin' the interview. I picked you because -- frankly I never heard ...

Biotech leaders at a Stanford symposium normally focused on the future couldn’t help but grapple with a present clouded by ...

The Department of Health and Human Services said it is redirecting funding from what it calls a wasteful Biden-era project on ...

Eli Lilly’s stock wobbled Thursday after a looming coverage hit was detailed for its blockbuster weight-loss drug Zepbound.

The head of drugmaker Eli Lilly, which sells the popular weight-loss drug Zepbound, urged the Trump administration to ease up on its [tariff rollout]( ...

A Utah manufacturer says the truth prevailed. But a former federal regulator believes the dismissal of the case against Xlear ...

Recent reorganizations and "reductions in force" at the FDA have damaged the very backbone of our public health system.

After President Trump’s first nominee to lead the Centers for Disease Control and Prevention (CDC) failed to gain traction ...